Growth Hormone Secretagogue
7 compounds in this category.
CJC-1295
Category 1CJC-1295 with DAC, CJC-1295 no DAC
A synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce more growth…
Route
SubQ
Dose
100–300 mcg (no DAC) / 1–2 mg (with DAC)
Cycle
8–12 weeks on, 4 weeks off
Ipamorelin
Category 1A selective growth hormone secretagogue that stimulates GH release with minimal effects on cortisol and prolactin. Consi…
Route
SubQ
Dose
100–300 mcg
Cycle
8–12 weeks on, 4 weeks off
Sermorelin
Category 1Geref, GRF 1-29
A synthetic analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH). One of the longest-studied GH…
Route
SubQ
Dose
200–500 mcg
Cycle
3–6 months (longer cycles than other GHS due to gentler action)
Hexarelin
Category 1Examorelin, His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH2
A synthetic hexapeptide growth hormone secretagogue and one of the most potent GH-releasing peptides known. Stimulates G…
Route
SubQ
Dose
100–200 mcg
Cycle
4–8 weeks, then 4 weeks off (desensitization risk)
Tesamorelin
FDA ApprovedEgrifta, TH9507
A synthetic analog of growth hormone-releasing hormone (GHRH) that is FDA-approved for HIV-associated lipodystrophy. One…
Route
SubQ (Egrifta — FDA-approved)
Dose
2 mg
Cycle
Ongoing for approved indication; 12–26 weeks for off-label use
GHRP-6
Category 1Growth Hormone Releasing Peptide-6, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
One of the original synthetic growth hormone secretagogues, developed in the 1980s. A hexapeptide that strongly stimulat…
Route
SubQ
Dose
100–300 mcg
Cycle
8–12 weeks on, 4 weeks off
GHRP-2
UnregulatedGrowth Hormone Releasing Peptide-2, Pralmorelin
A synthetic hexapeptide growth hormone secretagogue that stimulates GH release through the ghrelin receptor. Considered …
Route
SubQ
Dose
100–300 mcg
Cycle
8–12 weeks on, 4 weeks off